On November 23, 2022 Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, reported that the management team will participate in and attend one-on-one meetings at two upcoming investor conferences (Press release, Gracell Biotechnologies, NOV 23, 2022, View Source [SID1234624407]).
Piper Sandler 34th Annual Healthcare Conference
Presentation: November 30th at 4:00 pm ET
One-on-one meetings: Wednesday, November 30, 2022
Location: New York, NY
JMP Securities Hematology & Oncology Summit (virtual)
Presentation: December 7th at 10:00 am ET
One-on-one meetings: December 6 – 7, 2022
Webcast of the fireside chat will be available on the News and Events section of Gracell’s investor website. A replay of the webcast will be available for 30 days following the event.